Search

everythinglearnresearchcommunity

for

Search:↓

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

TNF-alpha inhibitors can cause various immune-related skin issues.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

EGFR inhibitors for lung cancer can cause severe skin issues.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Targeting regulatory T cells may help treat age-related diseases.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

Ionizing radiation causes irreversible skin damage, with single doses leading to acute injury and hair graying, and fractional doses causing more severe long-term tissue damage.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.